BridgeBio Pharma
BridgeBio is a biotechnology company designing transformative medicines for patients with genetic diseases and cancers with clear genetic drivers.
BridgeBio Pharma has 68 open roles live. 10% of BridgeBio Pharma's open roles are remote, and BridgeBio Pharma hires most in San Francisco, United States (11 roles). These figures are read directly from BridgeBio Pharma's Greenhouse careers page. Most recent opening posted 20 October 2026.
ReqHunt Remote Index — location data incomplete for this company. How the ReqHunt Remote Index works — the four bands, the 10-role floor, why hybrid is excluded, and why companies with incomplete location data are withheld rather than scored low.
Read straight from BridgeBio Pharma's careers page (greenhouse). Each company's careers page is read about once an hour. “No longer listed” means the role has left the company's careers feed. That can mean filled, cancelled or withdrawn — the feed does not say which.
- Is BridgeBio Pharma hiring?
- Yes — BridgeBio Pharma has 68 open roles.
- Is BridgeBio Pharma hiring remotely?
- Yes — 10% of BridgeBio Pharma's open roles are remote (about 7 of 68).
- Where does BridgeBio Pharma hire most?
- BridgeBio Pharma hires most in San Francisco, United States (11), Remote (United States) (5), Palo Alto, United States (3).
- How many BridgeBio Pharma roles were removed in the last 7 days?
- 20 roles are no longer listed on BridgeBio Pharma's careers feed in the last 7 days. “No longer listed” means the role has left the company's careers feed. That can mean filled, cancelled or withdrawn — the feed does not say which.
- Is BridgeBio Pharma's hiring accelerating or slowing?
- slowing — BridgeBio Pharma's open-role count is down 12% over the last 30 days.
Data source: ReqHunt — read from BridgeBio Pharma's Greenhouse careers page. https://reqhunt.com/company/bridgebio-pharma
Structured data for LLMs and AI crawlers is available at /company/bridgebio-pharma.md.
68 live roles
- Accounting ManagerSan Francisco - 1800 OwensAccounting & Finance
- Commercialization Project ManagerRemote - NetherlandsManufacturing
- Senior Director, Health Economics and Outcomes Research, InternationalZug, SwitzerlandMarket Access
- Director of Commercial ExcellenceSan Francisco - 1800 OwensCommercial
- Therapeutic Sales Specialist - Los AngelesRemote - USASales
- Senior/Executive Director, Business OperationsSan Francisco - 1800 OwensBusiness Dev & Operations
- Senior Director, Clinical DevelopmentSan Francisco - 1800 OwensClinical Development
- QA Operations - Drug Product, QA ManagerSan Francisco - 1800 OwensGMP QA
- Sr. Manager, Project ManagementSan Francisco - 1800 OwensManufacturing
- Sr Project ManagerSan Francisco - 1800 OwensManufacturing
- Senior Director, GTM Strategy & Portfolio PlanningSan Francisco - 1800 OwensCommercial
- Biostatistics Director, Medical AffairsRemote - USABiostatistics and Programming
- Director, Strategic FinancePalo Alto - 3160 PorterStrategic Finance & IR
- Associate Director, Portfolio IntelligencePalo Alto - 3160 PorterStrategic Finance & IR
- Associate Director, Biostatistics & AIRemote - USABiostatistics and Programming
- AD/Director, Regulatory Affairs CMCRemote - USARegulatory Affairs
- Director, Marketing – Achondroplasia CommunitySan Francisco - 1800 OwensMarketing
- Associate Director, Omnichannel AnalyticsPalo Alto - 3160 Porter; San Francisco - 1800 OwensCommercial Insights & Operations
- Director/Sr. Director Clinical PharmacologyRemote - USAClinical Pharmacology
- Sr. Clinical Research Associate/Clinical trial ManagerRemote - USAClinical Operations
Top locations where BridgeBio Pharma hires
Remote roles are counted here too, by the scope they are open to. 47 of 68 live roles carry no location or remote scope we can resolve, so they are not listed below.
- San Francisco, United States11 roles
- Remote (United States)5 roles
- Palo Alto, United States3 roles
- Remote (Netherlands)2 roles
BridgeBio Pharma role mix
- Other54%
- Operations28%
- Engineering12%
- Sales6%
- Lead & above74%
- Junior10%
- Mid9%
- Senior7%
About BridgeBio Pharma
Peak sales estimates include currently projected revenues from products with regulatory approval (Attruby in the US and Beyonttra outside of the US) and investigational product candidates, including Encaleret, BBP-418, and Infigratinib, which have not yet received FDA or other regulatory approval.
- Website
- bridgebio.com
- Company profile
BridgeBio Pharma news coverage
Track BridgeBio Pharma and thousands of other companies — new roles the moment they appear on the careers page.
Join free